Glycomine, Inc., a clinical-stage biotechnology company, has announced the initiation of dosing in...
Category - Pharmaceuticals
Case Study: PostNord TPL ensures GDP compliance with Vaisala’s...
PostNord TPL, part of the PostNord Group, operates one of the largest third-party logistics...
AbbVie shares Phase 2 EPCORE® NHL-6 data: outpatient first-full...
AbbVie has reported updated results from the Phase 2 EPCORE® NHL-6 study (NCT05451810) assessing...
Roche Receives CE Mark for Contivue Port Delivery Platform in...
Roche has announced that the European Union has granted CE Mark approval for Contivue®, its Port...
Bayer Presents VICTOR Phase III Results for Vericiguat in Heart...
Bayer has shared new data from the VICTOR Phase III vericiguat heart failure trial in patients with...
Boehringer Ingelheim and AnGes Sign Manufacturing Agreement for...
Boehringer Ingelheim and AnGes have strengthened their long-standing collaboration with a new...
BioNTech Secures Non-Exclusive License Agreement with CureVac...
BioNTech has reached an agreement with CureVac and GSK to settle ongoing patent disputes and secure...
Alligator Bioscience Highlights Mitazalimab R&D Progress...
Alligator Bioscience (Nasdaq Stockholm: ATORX), a clinical-stage biotechnology company specializing...
FluoGuide Accelerates FG001 Commercialization Through Industry...
Copenhagen, Denmark—10 August 2025 – FluoGuide A/S has released highlights from its live-recorded...
Sanofi’s rilzabrutinib earns orphan designation in the EU for...
The European Medicines Agency (EMA) has granted orphan drug designation to rilzabrutinib, Sanofi’s...